Malformacje jamiste
Zapobieganie i profilaktyka

Malformacje jamiste ośrodkowego układu nerwowego (OUN) stanowią złożone anomalie naczyniowe obarczone ryzykiem krwawienia śródczaszkowego. Około 25% przypadków ma charakter dziedziczny, co uzasadnia stosowanie testów genetycznych prenatalnych oraz poradnictwa genetycznego w rodzinach z licznymi malformacjami. Profilaktyka u pacjentów z rozpoznanymi malformacjami opiera się na modyfikacji stylu życia, w tym kontroli parametrów metabolicznych (ciśnienie tętnicze, cholesterol, glikemia), regularnej aktywności fizycznej (minimum 30 minut dziennie), eliminacji używek oraz prawidłowej diecie. Regularne coroczne badania kontrolne oraz szybka reakcja na objawy są kluczowe w ograniczaniu ryzyka powikłań. W zakresie farmakoterapii, najnowsze dane sugerują potencjalne korzyści terapii przeciwzakrzepowej, mimo wcześniejszych obaw o zwiększone ryzyko krwawienia, jednak konieczne są dalsze randomizowane badania kliniczne. Szczególną ostrożność wymaga stosowanie leków rozrzedzających krew, takich jak aspiryna czy ibuprofen, które mogą nasilać krwawienie.

Profilaktyka malformacji jamistych

Malformacje jamiste ośrodkowego układu nerwowego (OUN) to złożone anomalie naczyniowe, które wiążą się z ryzykiem krwawienia śródczaszkowego. Obecnie nie istnieją skuteczne metody zapobiegania powstawaniu malformacji jamistych – są to wady, których nie można przewidzieć ani im całkowicie zapobiec.123 Niemniej jednak, badania naukowe i praktyka kliniczna wskazują na możliwości ograniczania ryzyka powikłań oraz działania profilaktyczne u osób z rozpoznanymi już malformacjami.

Badania genetyczne i poradnictwo genetyczne

Około 25% przypadków malformacji jamistych ma charakter dziedziczny.4 Naukowcy mają nadzieję, że pogłębienie wiedzy na temat genów związanych z tymi nieprawidłowościami może w przyszłości otworzyć drogę do skutecznej profilaktyki.5 Obecnie dostępne są następujące opcje dla osób z grupy ryzyka:

  • Testy genetyczne prenatalne – zalecane dla pierwszej osoby w rodzinie z licznymi malformacjami jamistymi67
  • Poradnictwo genetyczne – istotne dla krewnych osób z udokumentowaną rodzinną postacią malformacji jamistych89

Modyfikacja stylu życia

Choć nie można zapobiec samemu powstaniu malformacji jamistych, odpowiednia modyfikacja stylu życia może zmniejszyć ryzyko krwawienia u osób z już zdiagnozowaną malformacją.1011 Zalecenia obejmują:

  • Kontrolę parametrów metabolicznych – utrzymywanie w zakresie prawidłowym ciśnienia tętniczego, cholesterolu oraz glikemii1213
  • Regularna aktywność fizyczna – minimum 30 minut codziennej aktywności fizycznej przez większość dni tygodnia1415
  • Eliminacja używek – unikanie wyrobów tytoniowych i ograniczenie spożycia alkoholu1617
  • Prawidłowa dieta – spożywanie świeżej, nieprzetworzonej żywności18
  • Regularne kontrole medyczne – coroczne badania kontrolne oraz szybki kontakt z lekarzem w przypadku pojawienia się niepokojących objawów1920

Farmakoterapia prewencyjna

Leki przeciwzakrzepowe

Tradycyjne wytyczne zalecały ostrożność w stosowaniu leków przeciwzakrzepowych (przeciwpłytkowych i przeciwkrzepliwych) u pacjentów z malformacjami jamistymi z obawy przed zwiększonym ryzykiem krwawienia. Jednakże, najnowsze badania wskazują, że terapia przeciwzakrzepowa może być faktycznie korzystna.2122

Przegląd systematyczny, metaanaliza i metaanaliza sieciowa sugerują, że terapia przeciwzakrzepowa może być związana ze zmniejszonym ryzykiem krwawienia śródczaszkowego u pacjentów z malformacjami jamistymi mózgu. Wyniki te należy jednak traktować jako generujące hipotezy, a do potwierdzenia ich znaczenia klinicznego potrzebne są randomizowane badania kliniczne.23

Należy zachować ostrożność przy stosowaniu leków rozrzedzających krew, takich jak aspiryna czy ibuprofen, ponieważ mogą one potencjalnie nasilać krwawienie w przypadku aktywnej malformacji.24 Konieczna jest szczegółowa konsultacja z lekarzem prowadzącym w celu oceny stosunku korzyści do ryzyka w indywidualnym przypadku.25

Propranolol

Obiecujące wyniki daje stosowanie propranololu w leczeniu malformacji jamistych mózgu. Choć lek ten nie jest powszechnie przepisywany w takich przypadkach, wykazano jego skuteczność u dzieci oraz ochronne działanie w zapobieganiu krwawieniom z malformacji jamistych u dorosłych.26

Badania wskazują, że monitorowanie poziomu monocytów CD14+/CD31+ oraz stężenia czynnika wzrostu śródbłonka naczyniowego (VEGF) może być użytecznym narzędziem przewidywania skuteczności klinicznej propranololu u pacjentów z malformacjami jamistymi mózgu.27 Wyniki tych badań potwierdzają zasadność stosowania propranololu w klinicznym zarządzaniu malformacjami jamistymi mózgu.28

Radiochirurgia zapobiegawcza

Głównym celem leczenia malformacji jamistych mózgu jest zapobieganie nawracającym krwawieniom i powikłaniom związanym z krwawieniem.29 Radiochirurgia stereotaktyczna Gamma Knife (GKS) może stanowić skuteczną metodę zapobiegania krwawieniom, zwłaszcza w przypadku malformacji zlokalizowanych w trudno dostępnych chirurgicznie obszarach mózgowia.

Badania wykazały, że GKS zmniejsza roczną częstość występowania krwawienia w malformacjach jamistych pnia mózgu z 31,3% do 4,29% (w ciągu 2 lat) i do 3,64% (po upływie 2 lat).30 Obserwowane zmniejszenie rocznej częstości krwawienia po GKS może być przypisane opóźnionemu zamknięciu kanałów naczyniowych.31

Chociaż radiochirurgia może nie zapewniać definitywnego wyleczenia pacjentów z malformacjami jamistymi, jej minimalnie inwazyjny charakter może stanowić bezpieczniejszą alternatywę dla pacjentów z malformacjami niedostępnymi chirurgicznie lub dla osób z chorobami współistniejącymi, które wykluczają konwencjonalną operację.32 Coraz więcej dowodów potwierdza, że GKS zmniejsza ryzyko krwawienia w malformacjach jamistych, co czyni tę metodę opcją terapeutyczną dla pacjentów z malformacjami zlokalizowanymi w funkcjonalnie istotnych obszarach mózgu.33

Podsumowanie działań profilaktycznych

Obecnie nie istnieją metody zapobiegania powstawaniu malformacji jamistych, jednak u pacjentów z już rozpoznaną malformacją można wdrożyć działania profilaktyczne mające na celu zmniejszenie ryzyka krwawienia i związanych z nim powikłań. Obejmują one:

  • Badania genetyczne i poradnictwo dla rodzin z występowaniem malformacji jamistych3435
  • Modyfikację stylu życia – kontrolę parametrów metabolicznych, regularną aktywność fizyczną, eliminację używek3637
  • Farmakoterapię – rozważenie terapii propranololem oraz indywidualnej oceny korzyści ze stosowania leków przeciwzakrzepowych3839
  • Radiochirurgię Gamma Knife jako metodę zmniejszającą ryzyko krwawienia w przypadku malformacji zlokalizowanych w trudno dostępnych obszarach mózgu40

Kluczową rolę odgrywa indywidualizacja podejścia terapeutycznego oraz regularna kontrola lekarska. Mimo że całkowita profilaktyka malformacji jamistych nie jest obecnie możliwa, odpowiednie postępowanie medyczne może znacząco zmniejszyć ryzyko powikłań i poprawić jakość życia pacjentów.4142

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 11.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 UC San Diego Health Health Library | San Diego Hospital, Healthcare
    https://myhealth.ucsd.edu/RelatedItems/134,71
    Currently, cavernous malformations cant be prevented. Researchers hope that by learning more about the genes linked to these growths, prevention could become possible. […] Prenatal genetic testing and counseling are choices for the first person in a family with multiple cavernous malformations or for relatives of those with a family history.
  • #2 Cavernous Malformations
    https://www.nm.org/conditions-and-care-areas/neurosciences/cavernous-malformations
    Currently, cavernous malformations cant be prevented. […] Researchers hope that by learning more about the genes linked to these growths, prevention could become possible. […] Prenatal genetic testing and counseling are choices for the first person in a family with multiple cavernous malformations or for relatives of those with a family history.
  • #3 Cavernous Malformations – SeattleNeurosciences.com
    https://seattleneurosciences.com/conditions/cavernous-malformations/
    There are no current guidelines to prevent the occurrence of cavernous malformations.
  • #4 Cavernous Malformation Los Angeles, CA | Brain Surgery Encino, CA
    https://www.astraneuro.com/cavernous-malformation-neurosurgeon-los-angeles-encino-ca/
    Cavernous malformations cannot be prevented and approximately 1 in 4 cases of malformations are inherited. Hence, prenatal genetic counseling and testing are good options for a first person in a family diagnosed with multiple cavernous malformations or for relatives of those with established familial cavernous malformations.
  • #5 UC San Diego Health Health Library | San Diego Hospital, Healthcare
    https://myhealth.ucsd.edu/RelatedItems/134,71
    Currently, cavernous malformations cant be prevented. Researchers hope that by learning more about the genes linked to these growths, prevention could become possible. […] Prenatal genetic testing and counseling are choices for the first person in a family with multiple cavernous malformations or for relatives of those with a family history.
  • #6 Cavernous Malformations
    https://www.nm.org/conditions-and-care-areas/neurosciences/cavernous-malformations
    Currently, cavernous malformations cant be prevented. […] Researchers hope that by learning more about the genes linked to these growths, prevention could become possible. […] Prenatal genetic testing and counseling are choices for the first person in a family with multiple cavernous malformations or for relatives of those with a family history.
  • #7 What is a Cavernous Hemangioma?
    https://www.vejthani.com/2023/08/what-is-a-cavernous-hemangioma/
    In most cases, it is impossible to prevent cavernous malformations because of the nature of malformation we cannot predict. […] But if there is a high chance of a genetic condition, pregenetic testing can be done. […] Not modifying daily lifestyle can cause a high probability of hemorrhage. […] Ensure your blood pressure, cholesterol, and glucose level are within the range. […] Some medications like aspirin and ibuprofen can cause thin blood vessels. […] They may worsen the bleeding if they are present in your body during malformations. […] Preventive measures include: […] Refraining from smoking and alcohol. […] Exercising for at least 30 minutes daily. […] Getting an annual checkup. […] Consuming fresh food.
  • #8 UC San Diego Health Health Library | San Diego Hospital, Healthcare
    https://myhealth.ucsd.edu/RelatedItems/134,71
    Currently, cavernous malformations cant be prevented. Researchers hope that by learning more about the genes linked to these growths, prevention could become possible. […] Prenatal genetic testing and counseling are choices for the first person in a family with multiple cavernous malformations or for relatives of those with a family history.
  • #9 Cavernous Malformation Los Angeles, CA | Brain Surgery Encino, CA
    https://www.astraneuro.com/cavernous-malformation-neurosurgeon-los-angeles-encino-ca/
    Cavernous malformations cannot be prevented and approximately 1 in 4 cases of malformations are inherited. Hence, prenatal genetic counseling and testing are good options for a first person in a family diagnosed with multiple cavernous malformations or for relatives of those with established familial cavernous malformations.
  • #10 Cavernous Malformation (Cavernoma): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/21594-cavernous-hemangioma
    Theres no known way to prevent cavernous malformations. If you have a family history of these hemangiomas, your provider will discuss genetic testing and genetic counseling to help you learn more about this condition. […] While you cant prevent all cavernoma bleeds or ruptures, you can reduce your risk by taking care of your general health. You can do this by: Managing your blood pressure, cholesterol and blood glucose levels to be in a healthy range for you and your body. Talking to your provider about any medications you currently take to see if they increase your risk of bleeds (especially blood thinners). Getting at least 30 minutes of physical activity most days of the week. Avoiding the use of tobacco products. Getting regular checkups with a healthcare provider and contacting them if you have any questions or concerns.
  • #11 What is a Cavernous Hemangioma?
    https://www.vejthani.com/2023/08/what-is-a-cavernous-hemangioma/
    In most cases, it is impossible to prevent cavernous malformations because of the nature of malformation we cannot predict. […] But if there is a high chance of a genetic condition, pregenetic testing can be done. […] Not modifying daily lifestyle can cause a high probability of hemorrhage. […] Ensure your blood pressure, cholesterol, and glucose level are within the range. […] Some medications like aspirin and ibuprofen can cause thin blood vessels. […] They may worsen the bleeding if they are present in your body during malformations. […] Preventive measures include: […] Refraining from smoking and alcohol. […] Exercising for at least 30 minutes daily. […] Getting an annual checkup. […] Consuming fresh food.
  • #12 Cavernous Malformation (Cavernoma): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/21594-cavernous-hemangioma
    Theres no known way to prevent cavernous malformations. If you have a family history of these hemangiomas, your provider will discuss genetic testing and genetic counseling to help you learn more about this condition. […] While you cant prevent all cavernoma bleeds or ruptures, you can reduce your risk by taking care of your general health. You can do this by: Managing your blood pressure, cholesterol and blood glucose levels to be in a healthy range for you and your body. Talking to your provider about any medications you currently take to see if they increase your risk of bleeds (especially blood thinners). Getting at least 30 minutes of physical activity most days of the week. Avoiding the use of tobacco products. Getting regular checkups with a healthcare provider and contacting them if you have any questions or concerns.
  • #13 What is a Cavernous Hemangioma?
    https://www.vejthani.com/2023/08/what-is-a-cavernous-hemangioma/
    In most cases, it is impossible to prevent cavernous malformations because of the nature of malformation we cannot predict. […] But if there is a high chance of a genetic condition, pregenetic testing can be done. […] Not modifying daily lifestyle can cause a high probability of hemorrhage. […] Ensure your blood pressure, cholesterol, and glucose level are within the range. […] Some medications like aspirin and ibuprofen can cause thin blood vessels. […] They may worsen the bleeding if they are present in your body during malformations. […] Preventive measures include: […] Refraining from smoking and alcohol. […] Exercising for at least 30 minutes daily. […] Getting an annual checkup. […] Consuming fresh food.
  • #14 Cavernous Malformation (Cavernoma): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/21594-cavernous-hemangioma
    Theres no known way to prevent cavernous malformations. If you have a family history of these hemangiomas, your provider will discuss genetic testing and genetic counseling to help you learn more about this condition. […] While you cant prevent all cavernoma bleeds or ruptures, you can reduce your risk by taking care of your general health. You can do this by: Managing your blood pressure, cholesterol and blood glucose levels to be in a healthy range for you and your body. Talking to your provider about any medications you currently take to see if they increase your risk of bleeds (especially blood thinners). Getting at least 30 minutes of physical activity most days of the week. Avoiding the use of tobacco products. Getting regular checkups with a healthcare provider and contacting them if you have any questions or concerns.
  • #15 What is a Cavernous Hemangioma?
    https://www.vejthani.com/2023/08/what-is-a-cavernous-hemangioma/
    In most cases, it is impossible to prevent cavernous malformations because of the nature of malformation we cannot predict. […] But if there is a high chance of a genetic condition, pregenetic testing can be done. […] Not modifying daily lifestyle can cause a high probability of hemorrhage. […] Ensure your blood pressure, cholesterol, and glucose level are within the range. […] Some medications like aspirin and ibuprofen can cause thin blood vessels. […] They may worsen the bleeding if they are present in your body during malformations. […] Preventive measures include: […] Refraining from smoking and alcohol. […] Exercising for at least 30 minutes daily. […] Getting an annual checkup. […] Consuming fresh food.
  • #16 Cavernous Malformation (Cavernoma): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/21594-cavernous-hemangioma
    Theres no known way to prevent cavernous malformations. If you have a family history of these hemangiomas, your provider will discuss genetic testing and genetic counseling to help you learn more about this condition. […] While you cant prevent all cavernoma bleeds or ruptures, you can reduce your risk by taking care of your general health. You can do this by: Managing your blood pressure, cholesterol and blood glucose levels to be in a healthy range for you and your body. Talking to your provider about any medications you currently take to see if they increase your risk of bleeds (especially blood thinners). Getting at least 30 minutes of physical activity most days of the week. Avoiding the use of tobacco products. Getting regular checkups with a healthcare provider and contacting them if you have any questions or concerns.
  • #17 What is a Cavernous Hemangioma?
    https://www.vejthani.com/2023/08/what-is-a-cavernous-hemangioma/
    In most cases, it is impossible to prevent cavernous malformations because of the nature of malformation we cannot predict. […] But if there is a high chance of a genetic condition, pregenetic testing can be done. […] Not modifying daily lifestyle can cause a high probability of hemorrhage. […] Ensure your blood pressure, cholesterol, and glucose level are within the range. […] Some medications like aspirin and ibuprofen can cause thin blood vessels. […] They may worsen the bleeding if they are present in your body during malformations. […] Preventive measures include: […] Refraining from smoking and alcohol. […] Exercising for at least 30 minutes daily. […] Getting an annual checkup. […] Consuming fresh food.
  • #18 What is a Cavernous Hemangioma?
    https://www.vejthani.com/2023/08/what-is-a-cavernous-hemangioma/
    In most cases, it is impossible to prevent cavernous malformations because of the nature of malformation we cannot predict. […] But if there is a high chance of a genetic condition, pregenetic testing can be done. […] Not modifying daily lifestyle can cause a high probability of hemorrhage. […] Ensure your blood pressure, cholesterol, and glucose level are within the range. […] Some medications like aspirin and ibuprofen can cause thin blood vessels. […] They may worsen the bleeding if they are present in your body during malformations. […] Preventive measures include: […] Refraining from smoking and alcohol. […] Exercising for at least 30 minutes daily. […] Getting an annual checkup. […] Consuming fresh food.
  • #19 Cavernous Malformation (Cavernoma): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/21594-cavernous-hemangioma
    Theres no known way to prevent cavernous malformations. If you have a family history of these hemangiomas, your provider will discuss genetic testing and genetic counseling to help you learn more about this condition. […] While you cant prevent all cavernoma bleeds or ruptures, you can reduce your risk by taking care of your general health. You can do this by: Managing your blood pressure, cholesterol and blood glucose levels to be in a healthy range for you and your body. Talking to your provider about any medications you currently take to see if they increase your risk of bleeds (especially blood thinners). Getting at least 30 minutes of physical activity most days of the week. Avoiding the use of tobacco products. Getting regular checkups with a healthcare provider and contacting them if you have any questions or concerns.
  • #20 What is a Cavernous Hemangioma?
    https://www.vejthani.com/2023/08/what-is-a-cavernous-hemangioma/
    In most cases, it is impossible to prevent cavernous malformations because of the nature of malformation we cannot predict. […] But if there is a high chance of a genetic condition, pregenetic testing can be done. […] Not modifying daily lifestyle can cause a high probability of hemorrhage. […] Ensure your blood pressure, cholesterol, and glucose level are within the range. […] Some medications like aspirin and ibuprofen can cause thin blood vessels. […] They may worsen the bleeding if they are present in your body during malformations. […] Preventive measures include: […] Refraining from smoking and alcohol. […] Exercising for at least 30 minutes daily. […] Getting an annual checkup. […] Consuming fresh food.
  • #21
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11010038/
    Cerebral cavernous malformations are complex vascular anomalies in the central nervous system associated with a risk of intracranial hemorrhage. Traditional guidelines have been cautious about the use of antithrombotic therapy in this patient group, citing concerns about potential bleeding risk. However, recent research posits that antithrombotic therapy may actually be beneficial. This study aims to clarify the association between antithrombotic therapy, including antiplatelet and anticoagulant medications, and the risk of intracranial hemorrhage in patients with cerebral cavernous malformations. […] Our study explores the potential benefits of antithrombotic therapy in cerebral cavernous malformations. Although the analysis suggests a possible role for antithrombotic agents, it is critical to note that the evidence remains preliminary.
  • #22
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11010038/
    Contrary to traditional guidelines, antithrombotic agents might have potential benefits in patients with cerebral cavernous malformation; however, due to inherent biases in the included studies, these findings should be considered hypothesis-generating, and randomized clinical trials are needed to ascertain their clinical significance. […] This systematic review, meta-analysis, and network meta-analysis indicates that antithrombotic therapy may be associated with a decreased risk of intracranial hemorrhage in patients with cerebral cavernous malformations. […] In conclusion, this study suggests that antithrombotic therapy is associated with decreased risk of intracranial hemorrhage. Further studies, including randomized clinical trials, are warranted to validate and further investigate these results.
  • #23
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11010038/
    Contrary to traditional guidelines, antithrombotic agents might have potential benefits in patients with cerebral cavernous malformation; however, due to inherent biases in the included studies, these findings should be considered hypothesis-generating, and randomized clinical trials are needed to ascertain their clinical significance. […] This systematic review, meta-analysis, and network meta-analysis indicates that antithrombotic therapy may be associated with a decreased risk of intracranial hemorrhage in patients with cerebral cavernous malformations. […] In conclusion, this study suggests that antithrombotic therapy is associated with decreased risk of intracranial hemorrhage. Further studies, including randomized clinical trials, are warranted to validate and further investigate these results.
  • #24 What is a Cavernous Hemangioma?
    https://www.vejthani.com/2023/08/what-is-a-cavernous-hemangioma/
    In most cases, it is impossible to prevent cavernous malformations because of the nature of malformation we cannot predict. […] But if there is a high chance of a genetic condition, pregenetic testing can be done. […] Not modifying daily lifestyle can cause a high probability of hemorrhage. […] Ensure your blood pressure, cholesterol, and glucose level are within the range. […] Some medications like aspirin and ibuprofen can cause thin blood vessels. […] They may worsen the bleeding if they are present in your body during malformations. […] Preventive measures include: […] Refraining from smoking and alcohol. […] Exercising for at least 30 minutes daily. […] Getting an annual checkup. […] Consuming fresh food.
  • #25 Cavernous Malformation (Cavernoma): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/21594-cavernous-hemangioma
    Theres no known way to prevent cavernous malformations. If you have a family history of these hemangiomas, your provider will discuss genetic testing and genetic counseling to help you learn more about this condition. […] While you cant prevent all cavernoma bleeds or ruptures, you can reduce your risk by taking care of your general health. You can do this by: Managing your blood pressure, cholesterol and blood glucose levels to be in a healthy range for you and your body. Talking to your provider about any medications you currently take to see if they increase your risk of bleeds (especially blood thinners). Getting at least 30 minutes of physical activity most days of the week. Avoiding the use of tobacco products. Getting regular checkups with a healthcare provider and contacting them if you have any questions or concerns.
  • #26 Propranolol therapy for cerebral cavernous malformations
    https://www.spandidos-publications.com/10.3892/wasj.2022.158
    Propranolol administration in patients with CCM, although not commonly prescribed, has effectively been used in children and appears to play a protective role in the prevention of CCM-derived hemorrhaging in adults. […] The present study highlights the monitorization of the levels of CD14+/CD31+ monocytes and VEGF levels as a useful tool for predicting the clinical efficacy of propranolol in patients with CCM. […] The findings of the present study reinforce the use of propranolol in the clinical management of CCM and points out the monitorization levels of monocytes (CD14+/CD31+) and VEGF in PB as useful tools which may be used to predict treatment efficacy.
  • #27 Propranolol therapy for cerebral cavernous malformations
    https://www.spandidos-publications.com/10.3892/wasj.2022.158
    Propranolol administration in patients with CCM, although not commonly prescribed, has effectively been used in children and appears to play a protective role in the prevention of CCM-derived hemorrhaging in adults. […] The present study highlights the monitorization of the levels of CD14+/CD31+ monocytes and VEGF levels as a useful tool for predicting the clinical efficacy of propranolol in patients with CCM. […] The findings of the present study reinforce the use of propranolol in the clinical management of CCM and points out the monitorization levels of monocytes (CD14+/CD31+) and VEGF in PB as useful tools which may be used to predict treatment efficacy.
  • #28 Propranolol therapy for cerebral cavernous malformations
    https://www.spandidos-publications.com/10.3892/wasj.2022.158
    Propranolol administration in patients with CCM, although not commonly prescribed, has effectively been used in children and appears to play a protective role in the prevention of CCM-derived hemorrhaging in adults. […] The present study highlights the monitorization of the levels of CD14+/CD31+ monocytes and VEGF levels as a useful tool for predicting the clinical efficacy of propranolol in patients with CCM. […] The findings of the present study reinforce the use of propranolol in the clinical management of CCM and points out the monitorization levels of monocytes (CD14+/CD31+) and VEGF in PB as useful tools which may be used to predict treatment efficacy.
  • #29 Gamma Knife radiosurgery for cerebral cavernous malformation | Scientific Reports
    https://www.nature.com/articles/s41598-019-56119-1
    Prevention of recurrent hemorrhage and hemorrhage-associated complications are the primary objectives of cerebral cavernous malformation (CCM) treatment. […] GKS also decreased the annual incidence of hemorrhage in brainstem CCMs from 31.3% to 4.29% (within 2 years) and to 3.64% (beyond 2 years). […] Although radiosurgery may not provide definitive cure for CCM patients, its minimally-invasive nature may provide a safer alternative for patients with surgically-inaccessible CCMs or those with medical comorbidities that preclude surgery. […] The observed decrease in the annual incidence of hemorrhage after GKS may be attributed to the delayed luminal closure of vascular channels. […] The data presented in our study adds to the mounting evidence that GKS decreases the risk of hemorrhage in CCMs. Therefore, GKS may be an option for patients with eloquently located CCMs.
  • #30 Gamma Knife radiosurgery for cerebral cavernous malformation | Scientific Reports
    https://www.nature.com/articles/s41598-019-56119-1
    Prevention of recurrent hemorrhage and hemorrhage-associated complications are the primary objectives of cerebral cavernous malformation (CCM) treatment. […] GKS also decreased the annual incidence of hemorrhage in brainstem CCMs from 31.3% to 4.29% (within 2 years) and to 3.64% (beyond 2 years). […] Although radiosurgery may not provide definitive cure for CCM patients, its minimally-invasive nature may provide a safer alternative for patients with surgically-inaccessible CCMs or those with medical comorbidities that preclude surgery. […] The observed decrease in the annual incidence of hemorrhage after GKS may be attributed to the delayed luminal closure of vascular channels. […] The data presented in our study adds to the mounting evidence that GKS decreases the risk of hemorrhage in CCMs. Therefore, GKS may be an option for patients with eloquently located CCMs.
  • #31 Gamma Knife radiosurgery for cerebral cavernous malformation | Scientific Reports
    https://www.nature.com/articles/s41598-019-56119-1
    Prevention of recurrent hemorrhage and hemorrhage-associated complications are the primary objectives of cerebral cavernous malformation (CCM) treatment. […] GKS also decreased the annual incidence of hemorrhage in brainstem CCMs from 31.3% to 4.29% (within 2 years) and to 3.64% (beyond 2 years). […] Although radiosurgery may not provide definitive cure for CCM patients, its minimally-invasive nature may provide a safer alternative for patients with surgically-inaccessible CCMs or those with medical comorbidities that preclude surgery. […] The observed decrease in the annual incidence of hemorrhage after GKS may be attributed to the delayed luminal closure of vascular channels. […] The data presented in our study adds to the mounting evidence that GKS decreases the risk of hemorrhage in CCMs. Therefore, GKS may be an option for patients with eloquently located CCMs.
  • #32 Gamma Knife radiosurgery for cerebral cavernous malformation | Scientific Reports
    https://www.nature.com/articles/s41598-019-56119-1
    Prevention of recurrent hemorrhage and hemorrhage-associated complications are the primary objectives of cerebral cavernous malformation (CCM) treatment. […] GKS also decreased the annual incidence of hemorrhage in brainstem CCMs from 31.3% to 4.29% (within 2 years) and to 3.64% (beyond 2 years). […] Although radiosurgery may not provide definitive cure for CCM patients, its minimally-invasive nature may provide a safer alternative for patients with surgically-inaccessible CCMs or those with medical comorbidities that preclude surgery. […] The observed decrease in the annual incidence of hemorrhage after GKS may be attributed to the delayed luminal closure of vascular channels. […] The data presented in our study adds to the mounting evidence that GKS decreases the risk of hemorrhage in CCMs. Therefore, GKS may be an option for patients with eloquently located CCMs.
  • #33 Gamma Knife radiosurgery for cerebral cavernous malformation | Scientific Reports
    https://www.nature.com/articles/s41598-019-56119-1
    Prevention of recurrent hemorrhage and hemorrhage-associated complications are the primary objectives of cerebral cavernous malformation (CCM) treatment. […] GKS also decreased the annual incidence of hemorrhage in brainstem CCMs from 31.3% to 4.29% (within 2 years) and to 3.64% (beyond 2 years). […] Although radiosurgery may not provide definitive cure for CCM patients, its minimally-invasive nature may provide a safer alternative for patients with surgically-inaccessible CCMs or those with medical comorbidities that preclude surgery. […] The observed decrease in the annual incidence of hemorrhage after GKS may be attributed to the delayed luminal closure of vascular channels. […] The data presented in our study adds to the mounting evidence that GKS decreases the risk of hemorrhage in CCMs. Therefore, GKS may be an option for patients with eloquently located CCMs.
  • #34 UC San Diego Health Health Library | San Diego Hospital, Healthcare
    https://myhealth.ucsd.edu/RelatedItems/134,71
    Currently, cavernous malformations cant be prevented. Researchers hope that by learning more about the genes linked to these growths, prevention could become possible. […] Prenatal genetic testing and counseling are choices for the first person in a family with multiple cavernous malformations or for relatives of those with a family history.
  • #35 Cavernous Malformation Los Angeles, CA | Brain Surgery Encino, CA
    https://www.astraneuro.com/cavernous-malformation-neurosurgeon-los-angeles-encino-ca/
    Cavernous malformations cannot be prevented and approximately 1 in 4 cases of malformations are inherited. Hence, prenatal genetic counseling and testing are good options for a first person in a family diagnosed with multiple cavernous malformations or for relatives of those with established familial cavernous malformations.
  • #36 Cavernous Malformation (Cavernoma): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/21594-cavernous-hemangioma
    Theres no known way to prevent cavernous malformations. If you have a family history of these hemangiomas, your provider will discuss genetic testing and genetic counseling to help you learn more about this condition. […] While you cant prevent all cavernoma bleeds or ruptures, you can reduce your risk by taking care of your general health. You can do this by: Managing your blood pressure, cholesterol and blood glucose levels to be in a healthy range for you and your body. Talking to your provider about any medications you currently take to see if they increase your risk of bleeds (especially blood thinners). Getting at least 30 minutes of physical activity most days of the week. Avoiding the use of tobacco products. Getting regular checkups with a healthcare provider and contacting them if you have any questions or concerns.
  • #37 What is a Cavernous Hemangioma?
    https://www.vejthani.com/2023/08/what-is-a-cavernous-hemangioma/
    In most cases, it is impossible to prevent cavernous malformations because of the nature of malformation we cannot predict. […] But if there is a high chance of a genetic condition, pregenetic testing can be done. […] Not modifying daily lifestyle can cause a high probability of hemorrhage. […] Ensure your blood pressure, cholesterol, and glucose level are within the range. […] Some medications like aspirin and ibuprofen can cause thin blood vessels. […] They may worsen the bleeding if they are present in your body during malformations. […] Preventive measures include: […] Refraining from smoking and alcohol. […] Exercising for at least 30 minutes daily. […] Getting an annual checkup. […] Consuming fresh food.
  • #38
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11010038/
    Contrary to traditional guidelines, antithrombotic agents might have potential benefits in patients with cerebral cavernous malformation; however, due to inherent biases in the included studies, these findings should be considered hypothesis-generating, and randomized clinical trials are needed to ascertain their clinical significance. […] This systematic review, meta-analysis, and network meta-analysis indicates that antithrombotic therapy may be associated with a decreased risk of intracranial hemorrhage in patients with cerebral cavernous malformations. […] In conclusion, this study suggests that antithrombotic therapy is associated with decreased risk of intracranial hemorrhage. Further studies, including randomized clinical trials, are warranted to validate and further investigate these results.
  • #39 Propranolol therapy for cerebral cavernous malformations
    https://www.spandidos-publications.com/10.3892/wasj.2022.158
    Propranolol administration in patients with CCM, although not commonly prescribed, has effectively been used in children and appears to play a protective role in the prevention of CCM-derived hemorrhaging in adults. […] The present study highlights the monitorization of the levels of CD14+/CD31+ monocytes and VEGF levels as a useful tool for predicting the clinical efficacy of propranolol in patients with CCM. […] The findings of the present study reinforce the use of propranolol in the clinical management of CCM and points out the monitorization levels of monocytes (CD14+/CD31+) and VEGF in PB as useful tools which may be used to predict treatment efficacy.
  • #40 Gamma Knife radiosurgery for cerebral cavernous malformation | Scientific Reports
    https://www.nature.com/articles/s41598-019-56119-1
    Prevention of recurrent hemorrhage and hemorrhage-associated complications are the primary objectives of cerebral cavernous malformation (CCM) treatment. […] GKS also decreased the annual incidence of hemorrhage in brainstem CCMs from 31.3% to 4.29% (within 2 years) and to 3.64% (beyond 2 years). […] Although radiosurgery may not provide definitive cure for CCM patients, its minimally-invasive nature may provide a safer alternative for patients with surgically-inaccessible CCMs or those with medical comorbidities that preclude surgery. […] The observed decrease in the annual incidence of hemorrhage after GKS may be attributed to the delayed luminal closure of vascular channels. […] The data presented in our study adds to the mounting evidence that GKS decreases the risk of hemorrhage in CCMs. Therefore, GKS may be an option for patients with eloquently located CCMs.
  • #41 Cavernous Malformation (Cavernoma): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/21594-cavernous-hemangioma
    Theres no known way to prevent cavernous malformations. If you have a family history of these hemangiomas, your provider will discuss genetic testing and genetic counseling to help you learn more about this condition. […] While you cant prevent all cavernoma bleeds or ruptures, you can reduce your risk by taking care of your general health. You can do this by: Managing your blood pressure, cholesterol and blood glucose levels to be in a healthy range for you and your body. Talking to your provider about any medications you currently take to see if they increase your risk of bleeds (especially blood thinners). Getting at least 30 minutes of physical activity most days of the week. Avoiding the use of tobacco products. Getting regular checkups with a healthcare provider and contacting them if you have any questions or concerns.
  • #42 Gamma Knife radiosurgery for cerebral cavernous malformation | Scientific Reports
    https://www.nature.com/articles/s41598-019-56119-1
    Prevention of recurrent hemorrhage and hemorrhage-associated complications are the primary objectives of cerebral cavernous malformation (CCM) treatment. […] GKS also decreased the annual incidence of hemorrhage in brainstem CCMs from 31.3% to 4.29% (within 2 years) and to 3.64% (beyond 2 years). […] Although radiosurgery may not provide definitive cure for CCM patients, its minimally-invasive nature may provide a safer alternative for patients with surgically-inaccessible CCMs or those with medical comorbidities that preclude surgery. […] The observed decrease in the annual incidence of hemorrhage after GKS may be attributed to the delayed luminal closure of vascular channels. […] The data presented in our study adds to the mounting evidence that GKS decreases the risk of hemorrhage in CCMs. Therefore, GKS may be an option for patients with eloquently located CCMs.